AMF Pensionsforsakring AB Has $65.02 Million Holdings in Colgate-Palmolive (CL)

AMF Pensionsforsakring AB decreased its position in shares of Colgate-Palmolive (NYSE:CL) by 4.9% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 907,080 shares of the company’s stock after selling 46,619 shares during the quarter. AMF Pensionsforsakring AB owned about 0.10% of Colgate-Palmolive worth $65,019,000 as of its most recent SEC filing.

Other institutional investors have also recently added to or reduced their stakes in the company. Virtue Capital Management LLC acquired a new stake in shares of Colgate-Palmolive during the 4th quarter worth approximately $104,000. Centerpoint Advisors LLC acquired a new stake in shares of Colgate-Palmolive during the 1st quarter worth approximately $112,000. Princeton Capital Management LLC acquired a new stake in shares of Colgate-Palmolive during the 1st quarter worth approximately $117,000. Calton & Associates Inc. acquired a new stake in shares of Colgate-Palmolive during the 4th quarter worth approximately $126,000. Finally, Cerebellum GP LLC acquired a new stake in shares of Colgate-Palmolive during the 4th quarter worth approximately $129,000. Hedge funds and other institutional investors own 73.30% of the company’s stock.

Colgate-Palmolive opened at $62.72 on Thursday, according to Marketbeat. Colgate-Palmolive has a 12-month low of $61.28 and a 12-month high of $77.91. The company has a debt-to-equity ratio of 64.85, a current ratio of 1.08 and a quick ratio of 0.75. The firm has a market capitalization of $54.30 billion, a P/E ratio of 21.85, a price-to-earnings-growth ratio of 2.46 and a beta of 0.75.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, April 27th. The company reported $0.74 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.73 by $0.01. Colgate-Palmolive had a net margin of 13.30% and a return on equity of 1,486.69%. The business had revenue of $4 billion during the quarter, compared to the consensus estimate of $4.01 billion. During the same quarter last year, the firm posted $0.67 EPS. Colgate-Palmolive’s revenue was up 6.4% compared to the same quarter last year. sell-side analysts expect that Colgate-Palmolive will post 3.17 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which was paid on Tuesday, May 15th. Investors of record on Friday, April 20th were given a $0.42 dividend. The ex-dividend date of this dividend was Thursday, April 19th. This represents a $1.68 annualized dividend and a yield of 2.68%. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.40. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 58.54%.

In other Colgate-Palmolive news, SVP John J. Huston sold 16,079 shares of the firm’s stock in a transaction on Thursday, May 10th. The stock was sold at an average price of $62.32, for a total transaction of $1,002,043.28. Following the transaction, the senior vice president now directly owns 84,512 shares in the company, valued at approximately $5,266,787.84. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Daniel B. Marsili sold 19,500 shares of the firm’s stock in a transaction on Monday, April 16th. The shares were sold at an average price of $71.85, for a total value of $1,401,075.00. Following the transaction, the insider now owns 77,935 shares in the company, valued at $5,599,629.75. The disclosure for this sale can be found here. In the last three months, insiders sold 142,079 shares of company stock valued at $8,981,683. 1.02% of the stock is currently owned by insiders.

Several analysts have recently commented on the stock. Jefferies Group reaffirmed a “hold” rating and set a $79.00 price objective on shares of Colgate-Palmolive in a research report on Friday, January 26th. Stifel Nicolaus reaffirmed a “hold” rating and set a $75.00 price objective on shares of Colgate-Palmolive in a research report on Wednesday, April 18th. Morgan Stanley reduced their price objective on shares of Colgate-Palmolive from $82.00 to $80.00 and set an “overweight” rating for the company in a research report on Friday, April 20th. Barclays set a $75.00 price objective on shares of Colgate-Palmolive and gave the stock a “hold” rating in a research report on Thursday, March 15th. Finally, Citigroup reduced their price objective on shares of Colgate-Palmolive from $80.00 to $73.00 and set a “neutral” rating for the company in a research report on Tuesday, May 1st. Four equities research analysts have rated the stock with a sell rating, ten have given a hold rating and three have issued a buy rating to the stock. The stock has an average rating of “Hold” and a consensus price target of $76.75.

About Colgate-Palmolive

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply